Chromosome comparative genomic hybridisation (CGH) |
Target DNA and normal reference DNA differentially labelled and applied to metaphase spread from cultured normal lymphocytes |
Genome-wide analysis |
Cannot detect balanced chromosomal alterations or polyploidy. Resolution limited by use of highly condensed metaphase chromosomes |
High-level amplification 250 kb Gains 2 Mb Losses 10 to 20 Mb [16] |
Discovery studies |
Array CGH (aCGH) |
Target DNA hybridised to DNA clones (for example, bacterial artificial chromosomes) or oligonucleotides placed at certain intervals through genome. |
Genome-wide analysis |
Cannot detect balanced chromosomal alterations or polyploidy. Prone to spatial bias. |
Determined by density of clone coverage |
Discovery studies |
Single-nucleotide polymorphism (SNP) arrays |
Target DNA hybridised to oligonucleotides specific to SNPs and compared with collection of controls |
Can detect loss of heterozygosity (LOH) and mutations. Normal reference DNA not required. |
May not be genome-wide analysis as SNPs are unevenly distributed across genome; however, commercially available arrays deliberately include probes in SNP-poor areas to increase genome coverage. Prone to spatial bias. |
Determined by length, density, and distribution of probes |
Discovery studies |
Molecular inversion probe array |
Target DNA amplified in SNP-dependent manner and hybridised to oligonucleotides |
Suitable for small amounts (<100 ng) of degraded DNA. Can detect LOH and mutations. |
As for SNP arrays |
Determined by density and distribution of probes |
Discovery studies |
Massively parallel sequencing |
Parallel sequencing of large numbers (potentially millions) of templates |
Potential genome-wide analysis. Can identify copy number neutral structural variations. Suitable for fragmented DNA. |
Large volume of sequencing and data analysis |
Potential single-base resolution |
Discovery studies |
Fluorescence in situ hybridisation |
Fluorescently labelled genomic clones hybridised to target interphase nuclei |
Structural rearrangements and polyploidy can be detected. |
Minimal multiplexing ability |
50 kb [17] |
Locus-specific copy number analysis |
Quantitative polymerase chain reaction (PCR) |
Quantitation of copy number based on rate of amplification |
Low DNA input requirements |
Limited multiplexing ability. Prone to PCR amplification bias. Precision dependent on number of replicates. Underestimates high copy numbers. |
Assay design dependent, but resolution of less than 100 base pairs (bp) possible. |
Locus-specific copy number analysis |
Droplet digital PCR |
Quantification of copy number based on Poisson distribution statistics of thousands of digital PCRs [18] |
Low DNA input requirements and compatible with fragmented DNA |
Minimal multiplexing ability. Cannot detect polyploidy. |
Targets regions of less than 100 bp possible. Can detect more than 0.15 % positive droplets per sample [19]. |
Locus-specific copy number analysis |
Multiplex amplification and probe hybridisation (MAPH)/multiplex ligation-dependent probe amplification |
Quantification of PCR products of hybridised probes |
Multiplexable |
Large amount of good-quality DNA required for MAPH (250 to 1,000 ng, >100 bp) [20] |
150 bp [21, 22] |
Locus-specific copy number analysis |
Nanostring nCounter system |
Absolute quantification of probes hybridised to target region |
Multiplexable. Requires fragments of 100 bp or greater |
Requires 300 ng of input DNA |
Detects 0 to 4 copies of minimum 100 bp target regions |
Locus-specific copy number analysis |